Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bulteau

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
L'Encephale|August 3, 2020
S Bulteau, C Baeken, E Poulet
Molecular Microbiology|February 13, 1999
Promoter element spacing controls basal expression and light inducibility of the cyanobacterial secA geneK Mazouni, S Bulteau, C Cassier-Chauvat, et al.
Molecular Microbiology|June 1, 1994
Light-regulated promoters from Synechocystis PCC6803 share a consensus motif involved in photoregulationP Marraccini, C Cassier-Chauvat, S Bulteau, et al.
Plant Molecular Biology|November 1, 1993
A conjugative plasmid vector for promoter analysis in several cyanobacteria of the genera Synechococcus and SynechocystisP Marraccini, S Bulteau, C Cassier-Chauvat, et al.
L'Encephale|March 12, 2023
[Ketamine and lorazepam combination as an alternative to electroconvulsive therapy for catatonia in late-life depression: A case report]A Laurin, N Capelle, N Bukowski, et al.
The British Journal of Dermatology|June 20, 2017
Psychiatric disorders with systemic retinoids: a systematic review of case reportsM Le Moigne, J-P Fournier, S Bulteau, et al.
Revue D'Epidemiologie Et De Sante Publique|July 7, 2015
[Hospital production cost of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression]F Etcheverrigaray, S Bulteau, L O Machon, et al.
La Revue De Medecine Interne|July 14, 2021
[Treatments for depression in consultation-liaison psychiatry: From theory to practice]A Sauvaget, M Guitteny, N Bukowski, et al.
Revue D'Epidemiologie Et De Sante Publique|March 21, 2017
[Treating depression with repetitive transcranial magnetic stimulation (rTMS): Which repayment of a leading activity in psychiatry?]F Etcheverrigaray, S Bulteau, L-O Machon, et al.
Expert Opinion on Drug Safety|August 9, 2016
Benzodiazepine dependence in subjects with alcohol use disorders: what prevalence?A Morel, M Grall-Bronnec, S Bulteau, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
L'Encephale|August 3, 2020
S Bulteau, C Baeken, E Poulet
Molecular Microbiology|February 13, 1999
Promoter element spacing controls basal expression and light inducibility of the cyanobacterial secA geneK Mazouni, S Bulteau, C Cassier-Chauvat, et al.
Molecular Microbiology|June 1, 1994
Light-regulated promoters from Synechocystis PCC6803 share a consensus motif involved in photoregulationP Marraccini, C Cassier-Chauvat, S Bulteau, et al.
Plant Molecular Biology|November 1, 1993
A conjugative plasmid vector for promoter analysis in several cyanobacteria of the genera Synechococcus and SynechocystisP Marraccini, S Bulteau, C Cassier-Chauvat, et al.
L'Encephale|March 12, 2023
[Ketamine and lorazepam combination as an alternative to electroconvulsive therapy for catatonia in late-life depression: A case report]A Laurin, N Capelle, N Bukowski, et al.
The British Journal of Dermatology|June 20, 2017
Psychiatric disorders with systemic retinoids: a systematic review of case reportsM Le Moigne, J-P Fournier, S Bulteau, et al.
Revue D'Epidemiologie Et De Sante Publique|July 7, 2015
[Hospital production cost of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression]F Etcheverrigaray, S Bulteau, L O Machon, et al.
La Revue De Medecine Interne|July 14, 2021
[Treatments for depression in consultation-liaison psychiatry: From theory to practice]A Sauvaget, M Guitteny, N Bukowski, et al.
Revue D'Epidemiologie Et De Sante Publique|March 21, 2017
[Treating depression with repetitive transcranial magnetic stimulation (rTMS): Which repayment of a leading activity in psychiatry?]F Etcheverrigaray, S Bulteau, L-O Machon, et al.
Expert Opinion on Drug Safety|August 9, 2016
Benzodiazepine dependence in subjects with alcohol use disorders: what prevalence?A Morel, M Grall-Bronnec, S Bulteau, et al.
Pageof 2